Results 51 to 60 of about 122,480 (182)
Pneumatic release of focal vitreomacular traction [PDF]
PurposeTo study the efficacy of a single intravitreal injection of expansile gas as a valuable alternative to current treatment options (conservative, pharmacological, and surgical) in patients with symptomatic, focal vitreomacular traction (VMT).Patients and methodsThis study comprises a retrospective, interventional case series of patients.
M G, Claus, E, Feron, M, Veckeneer
openaire +2 more sources
Purpose: Anti-vascular endothelial growth factor (VEGF) therapy is the most prevalent intervention for exudative lesions secondary to neovascular age-related macular degeneration (nAMD) and other macular neovascularization (MNV).
Aki Nihei +6 more
doaj +1 more source
ABSTRACT Background To compare the anatomical and functional outcomes of internal limiting membrane (ILM) flap and conventional ILM peeling in idiopathic full‐thickness macular holes (FTMHs). Methods Retrospective cohort study of all eyes treated with vitrectomy and ILM peeling (ILM‐P) with or without ILM flap (ILM‐F) for primary idiopathic FTMH repair
Zi Jin +13 more
wiley +1 more source
Bilateral Papillary Traction due to Persistent Hyaloid Vessel Remnants in Aymé–Gripp Syndrome
Introduction Although papillary traction often arises from anomalous vitreous detachment, it can be related to traction from persistent remnants of the fetal hyaloid vasculature. Case Presentation A 17‐year‐old girl with Aymé–Gripp syndrome was incidentally found to have bilateral optic nerve elevation in the setting of bilateral persistent hyaloid ...
Carolina Carvalho Soares Valentim +3 more
wiley +1 more source
Diabetic macular edema (DME) is the most common cause of moderate visual loss in diabetic patients. The current treatment of choice for center-involved DME is anti-vascular endothelial growth factor (VEGF) treatment.
Stephanie Flikier, Andres Wu, Lihteh Wu
doaj +1 more source
Spontaneous Resolution of Vitreomacular Traction in Two Patients with Diabetic Macular Edema
The nature of the vitreoretinal interface in conditions like diabetic macular edema (DME) remains incompletely understood. Furthermore, it is not clear what the role of pharmacological enzymatic vitreolysis will play in cases of vitreomacular traction ...
David R.P. Almeida +2 more
doaj +1 more source
We report two cases of pronounced development of proliferative vitreoretinopathy (PVR) within a few days after 23G revitrectomy with allogeneic platelet concentrate (PC) in persistent macular hole in 2023–2024. None of the cases had relevant risk factors for PVR development such as intraoperative retinal tears.
Patrick C. Fisel +4 more
wiley +1 more source
Acute vitreomacular traction syndrome after uneventful phacoemulsification
We prospectively evaluated 59 eyes following uneventful phacoemulsification and intraocular lens implantation with optic coherence tomography at one and seven postoperative days (POD).
Arikan, GÜL +5 more
core +1 more source
Bioelectrical activity of the retina after vitrectomy for vitreomacular traction syndrome
Purpose. According to the electrophysiological examination, a comparative analysis of the dynamics of electrogenesis of the retina after vitrectomy with vitreomacular traction syndrome.Material and methods.
E. N. Nikolaenko +4 more
doaj +1 more source
Purpose To evaluate prediction accuracy using the 4 new‐generation formulas (Barrett Universal II (BUII), Emmetropia Verifying Optical 2.0 (EVO), Kane, and Ladas Super Formula (LSF)) and 4 traditional formulas (Haigis, Hoffer Q, Holladay 1, and SRK/T) in eyes undergoing combined phacovitrectomy. Methods This is a retrospective case series study.
Shiming Cheng +10 more
wiley +1 more source

